Healthtech Startups

Antalgenics develops drugs and neurocosmetical products targeting dermatological and inflammatory conditions such as psoriatic pruritus, arthritic pain, and sensitive skin. The company focuses on pharmaceutical and cosmetic ingredient innovation for healthcare and personal care markets.

2 investors

Antengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates. It is listed on the Hong Kong Stock Exchange and works with global partners on oncology drug development.

2 investors

Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.

2 investors

Anuncia Medical develops medical technology focused on cerebrospinal fluid (CSF) science and clinical strategy to advance hydrocephalus treatment. The company combines decades of medtech expertise to serve the hydrocephalus care market.

2 investors

Anvil Diagnostics develops molecular diagnostic tests for invasive infections using proprietary SKIP-Seq technology that combines PCR speed with sequencing breadth. The company serves clinical laboratories and healthcare providers seeking rapid, direct-from-blood pathogen identification and antimicrobial guidance.

2 investors

Aō-Air develops proprietary air-seal hardware for respiratory protection that analyzes air volumes and flow conditions in real-time. The product uses integrated sensors to capture data and alert users to environmental threats, positioning it as an alternative to conventional facemasks.

2 investors

AorticLab develops medical devices and solutions for cardiovascular applications. The company focuses on innovative treatment platforms and educational programs for patients and healthcare professionals.

2 investors

Apaly operates an online platform that connects employers and their employees with advanced primary care providers, offering integrated healthcare services designed to reduce costs and improve quality and patient experience.

2 investors

2 investors

2 investors

An online store selling injectable and oral anabolic steroids, HGH, and post-cycle therapy products directly to consumers.

2 investors

Apexian Pharma is a biopharmaceutical company developing APX3330, an oral drug for treating Inflammatory Bowel Disease, including Crohn's disease and ulcerative colitis, as a single agent or in combination. It targets upstream modulation of inflammation for IBD patients who fail to achieve durable remission on current therapies.

2 investors

APIM Therapeutics is a clinical-stage oncology company developing first-in-class PCNA-targeting peptide therapeutics that disrupt cellular stress responses and address treatment resistance in cancer. Its lead candidate, ATX-101, has been evaluated in Phase Ib and Phase II clinical studies for ovarian cancer and soft tissue sarcoma.

2 investors

Apnimed develops investigational oral pharmaceutical therapies for obstructive sleep apnea (OSA), including its lead clinical candidate AD109, a neuromuscular approach intended to treat undertreated and untreated OSA patients. It is a clinical-stage pharmaceutical company focused on sleep apnea.

2 investors

Apostle develops cell-free DNA (cfDNA) extraction and purification kits for genomics and molecular biology laboratories. Its products are used to isolate DNA from plasma samples for downstream analysis, positioned as an alternative to established extraction kits.

2 investors

2 investors

Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.

2 investors

APrevent Medical develops medical implant devices, including a vocal implant system used to treat voice disorders. The company operates in the medical device industry.

2 investors

April Health provides mental healthcare integration tools and services for primary care providers, particularly serving underserved and rural communities where psychiatric specialists are scarce. The company deploys virtual behavioral health clinicians and consulting psychiatrists through a collaborative care model to help primary care providers manage growing mental health demands.

2 investors

Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials. The company operates in the vaccinology and biotech space.

2 investors

aptaTargets develops aptamer-based therapeutics and diagnostics for cerebrovascular diseases, with a lead program (ApTOLL) targeting stroke treatment. The company applies aptamer technology platforms to clinical applications in neurology.

2 investors

2 investors

The site presents ICON, a clinical research organization providing full-service drug development outsourcing, regulatory strategy, and clinical trial solutions for pharmaceutical and biotech sponsors. Its offerings include AI-enabled platforms for the clinical trial lifecycle, early-phase and bioanalytical services, cardiac safety monitoring, specialty laboratory services, and market access consulting.

2 investors

Aqualung Therapeutics is an early-stage therapeutics company developing a drug discovery platform and pipeline focused on advancing human health. It is affiliated with the University of Florida biotech ecosystem.

2 investors